InterventionsReview

Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways

American Journal of Hypertension

The paper

Sriperumbuduri S, Khan RW, Aftab S et al.

American Journal of Hypertension · 8 Sep 2026

doi.org/10.1093/ajh/hpag111 PubMed 42712144

RAS inhibitors linked to lower dementia risk than CCBs
Drugs & Aging · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Blood protein links to heart attacks vary with kidney function
Kidney Research and Clinical Practice · 6 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026